<unk>  is a monoclonal antibody that is FDA approved for the treatment of Cryopyrin-Associated Periodic Syndromes (CAPS),  Systemic Juvenile Idiopathic Arthritis (SJIA).   Common adverse reactions include Injection site reaction, diarrhea, gastroenteritis , nausea , upper abdominal pain (systemic juvenile idiopathic arthritis,  Infectious disease (systemic juvenile idiopathic arthritis, musculoskeletal pain, headache, vertigo, bronchitis, nasopharyngitis , pharyngitis, rhinitis.
Canakinumab
Briakinumab
Anakinra
Sarilumab
Nebacumab
Secukinumab
Belatacept
Avelumab